MedTrace Logo

Testing Effectiveness of Losartan in Patients With EoE With or Without a CTD

NCT01808196 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2020-09-24

Study results available
· View outcomes & findings →

Summary

The purpose of this research study is to test the safety of losartan potassium and see what effects (good and bad) it has on you and your eosinophilic esophagitis.

Conditions

  • Eosinophilic Esophagitis
  • Connective Tissue Disorders

Interventions

DRUG

Losartan Potassium

The dose of study drug is dependent on body weight and tolerance but did not exceed 100 mg.

Sponsors & Collaborators

  • Children's Hospital Medical Center, Cincinnati

    lead OTHER

Principal Investigators

  • J. Pablo Abonia, M.D. · Children's Hospital Medical Center, Cincinnati

  • Marc E Rothenberg, M.D., Ph.D. · Children's Hospital Medical Center, Cincinnati

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
5 Years
Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-10
Primary Completion
2015-01-13
Completion
2015-02-13

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01808196 on ClinicalTrials.gov